Disparities in burden of disease in patients with rheumatoid arthritis across racial and ethnic groups.

"Declarations Conflicts of interestJO, TB, MM, NM are employees of CorEvitas, LLC; SHP, KW are employees/stockholders of Bristol Myers Squibb; LRH is an employee and shareholder of CorEvitas, LLC, who is on the speaker’s bureau for Bristol Myers Squibb, and has received consulting fees from AbbVie, Bristol Myers Squibb and Roche and grant funding from Pfizer. Conflicts of interest JO, TB, MM, NM are employees of CorEvitas, LLC; SHP, KW are employees/stockholders of Bristol Myers Squibb; LRH is an employee and shareholder of CorEvitas, LLC, who is on the speaker’s bureau for Bristol Myers Squibb, and has received consulting fees from AbbVie, Bristol Myers Squibb and Roche and grant funding from Pfizer."

"Medical writing services were provided by Michelle D. Karpman, PhD, CorEvitas, LLC, and was funded by Bristol Myers Squibb, Princeton, New Jersey, USA. This study was sponsored by CorEvitas, LLC and the analysis was funded by Bristol Myers Squibb. Access to study data was limited to CorEvitas and CorEvitas statisticians completed all the analysis; all authors contributed to the interpretation of the results. CorEvitas has been supported through contracted subscriptions in the last two years by AbbVie, Amgen, Inc., Arena, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Chugai, Eli Lilly and Company, Genentech, Gilead Sciences, Inc., GlaxoSmithKline, Janssen Pharmaceuticals, Inc., LEO Pharma, Novartis, Ortho Dermatologics, Pfizer, Inc., Regeneron Pharmaceuticals, Inc., Sanofi, Sun Pharmaceutical Industries Ltd., and UCB S.A. The authors would like to thank all the investigators, their clinical staff, and patients who participate in CorEvitas’ Rheumatoid Arthritis Registry."